This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Collagen And HA-Based Biomaterials Industry

Table 60: European Historic Review for Collagen and HA-basedBiomaterials by Product Group/ Segment - Collagen BasedBiomaterials (Urinary Incontinence Products, CornealShields, Facial Aesthetic Dermal Fillersand WoundDressings); and Hyaluronic Acid Based Biomaterials(Viscosupplements, Viscoelastics and Facial Aesthetic DermalFillers) Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-40

Table 61: European 15-Year Perspective for Collagen andHA-based Biomaterials by Product Segment - PercentageBreakdown of Dollar Sales for Collagen Based Biomaterials(Urinary Incontinence Products, Corneal Shields, FacialAesthetic Dermal Fillersand Wound Dressings); and HyaluronicAcid Based Biomaterials (Viscosupplements, Viscoelastics andFacial Aesthetic Dermal Fillers) Markets for Years 2004,2012 & 2018 (includes corresponding Graph/Chart) III-41

4a. FRANCE III-42A.Market Analysis III-42Current and Future Analysis III-42Hyaluronic Acid Based Biomaterials III-42Collagen Based Biomaterials III-42Sanofi SA ( France) - A Key Player III-42B.Market Analytics III-43Table 62: French Recent Past, Current & Future Analysis forCollagen and HA-based Biomaterials by Product Group/Segment- Collagen Based Biomaterials (Urinary IncontinenceProducts, Corneal Shields, Facial Aesthetic DermalFillersand Wound Dressings); and Hyaluronic Acid BasedBiomaterials (Viscosupplements, Viscoelastics and FacialAesthetic Dermal Fillers) Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2010through 2018 (includes corresponding Graph/Chart) III-43

Table 63: French Historic Review for Collagen and HA-basedBiomaterials by Product Group/Segment - Collagen BasedBiomaterials (Urinary Incontinence Products, CornealShields, Facial Aesthetic Dermal Fillersand WoundDressings); and Hyaluronic Acid Based Biomaterials(Viscosupplements, Viscoelastics and Facial Aesthetic DermalFillers) Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-44

Table 64: French 15-Year Perspective for Collagen andHA-based Biomaterials by Product Segment - PercentageBreakdown of Dollar Sales for Collagen Based Biomaterials(Urinary Incontinence Products, Corneal Shields, FacialAesthetic Dermal Fillersand Wound Dressings); and HyaluronicAcid Based Biomaterials (Viscosupplements, Viscoelastics andFacial Aesthetic Dermal Fillers) Markets for Years 2004,2012 & 2018 (includes corresponding Graph/Chart) III-45

4b. GERMANY III-46A.Market Analysis III-46Current and Future Analysis III-46Hyaluronic Acid Based Biomaterials III-46Collagen Based Biomaterials III-46Strategic Corporate Developments III-46B.Market Analytics III-48Table 65: German Recent Past, Current & Future Analysis forCollagen and HA-based Biomaterials by Product Group/Segment- Collagen Based Biomaterials (Urinary IncontinenceProducts, Corneal Shields, Facial Aesthetic DermalFillersand Wound Dressings); and Hyaluronic Acid BasedBiomaterials (Viscosupplements, Viscoelastics and FacialAesthetic Dermal Fillers) Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2010through 2018 (includes corresponding Graph/Chart) III-48

Table 66: German Historic Review for Collagen and HA-basedBiomaterials by Product Group/Segment - Collagen BasedBiomaterials (Urinary Incontinence Products, CornealShields, Facial Aesthetic Dermal Fillersand WoundDressings); and Hyaluronic Acid Based Biomaterials(Viscosupplements, Viscoelastics and Facial Aesthetic DermalFillers) Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-49

9 of 12

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs